B2BReported founding year: 2012~11 peopleSan Francisco, CA, USA
Data-driven customer success platform for B2B SaaS.
Natero helps Customer Success Managers reduce churn, increase expansion, and manage more accounts with less effort.
Natero is the only Customer Success solution to combine predictive analytics, customer intelligence, and workflow management in a unified platform. This next generation solution helps B2B software providers prioritize, automate, and scale their Customer Success processes.
Pressurl: https://news.google.com/rss/articles/CBMiXEFVX3lxTFBLOVpkVWs0d0RTTGM3NVZmc1EtUTBaN1IyaUdrLXhaLUZaS1hEMW1YNjZpeHRKTXV1bWwzYmVfR19HamlQUjZwODJZcHg0ZDRCRTJIa0hDMUFxMjQz?oc=5 · headline: NTRA Stock Price and Chart — NASDAQ:NTRA · publication: TradingViewgoogle_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMi3AFBVV95cUxNMm51NzVuOF9idzJjUVE4ZHZkRC1PcjlBRzkteVNJSkdxaWlES2ZoYm9LMGdha3RYVkcxV3o5blp4VmhEZDN3MzVrTEtBTmYxWC0ydXNmWWhzaTRlbjVrVEpncVV3Qm9WQXNXbE5QNmg4UEhuQ19uMzB2MXFtcFA0Mk5MZDNOakgzR0NhbFpGVlp2Vml4d0M1ZFo3Q292NElaZVN4aW1SZC00UVVRZ01uTW80eVVyLUpLNVQwaDB3VVNkajVBSndXR1BLUDllRDNpYTRDNlJyYWswZjhC?oc=5 · headline: Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer · publication: Lelezardgoogle_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMitwFBVV95cUxQVWxWak4xZjhEekk3REdMd1RlSU85ZjJTN1dDU3BfRUVlck8tWGRzN2lqZVVBYVprVWh2NS1zVHVJVC1QbDM5d1QtaGtwUG1NRVlxRXNOWnl0cG45ejN1Yk1NUlREVTdFdnJMa0IxeUNGeW1WZmdPdTdkUjdCdnh2YXhLeU91ZlZlQVIxZC1LcTByVWw3NTVZekZpOHB5TlhrQmJTMENuU29UeGtoWjBQQ3EzeDhVYUk?oc=5 · headline: Natera Announces Q-Sub Filing with FDA for its Panorama® NIPT · publication: PR Newswiregoogle_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMi-gFBVV95cUxNdm5aaFVodkV5dGw3MXo4MDlkVHVXeTF3dkFNUkkza3M1bk5nV2ZwQlUyd1E1ejB5VUtiQnFXLWg5X0ZOWmNfcm5ZTmFHQ21xcjQxRU9ZNUl2d3ZoRlRKZ1pQNnhxYlJGLXczbjlYVVdxOTFwLUtFWUFTYWpXVjJNbTdEZ2F3Q0I4bVhzYWwwYVdBQ1NZa3o0bmlHT0U0b0xwVlRJS2JfWFVQVTB5TE9fa0N3ZGdaS280RTBhZUluZXg2MjdJV2dYN1h5UUtpb2NrUm1LQTlXTFNUdEJGYVBQa0ZlM0pMaGM5LWxBS0Q2SVNWY2syLXU0bWNB?oc=5 · headline: Matthew Rabinowitz, Natera Co-Founder and Executive Chairman of the Board, Makes Additional Investment in Natera · publication: PR Newswire
google_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMi3AFBVV95cUxOb3VUa0ZCWWwxOVgzZ3RLVWdMaVJ5NUsxdFNja2dzbVRISFl2QnZRSEFrVFYxcUgtWmpDTWJSUTVwS2tZcVhuZnhNaDVzQ1VsSXJ4S1ZwQkFmOEZjNVpYaHZiNDdxUE5IREZlNW5yV0NuSHVranZtTk1WWFdXcTBFa042ZXR4N1R1Mk14UXVtVi1vMnQ2YkF1dkVNTUxZUjgzN3lqbHFqY0lfdWdsSmhYd1MxVnBEWklFYXhSTHZLaVBTYkJ3SXowQ0N6c0ZOeVE0V2xvOC1mRnVuLW1f?oc=5 · headline: NCCN Recommends ctDNA-MRD Testing Using Signatera™ Technology in Landmark Bladder Cancer Guideline Update · publication: BioSpacegoogle_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMiuAFBVV95cUxNSkJ6dzJsaVc0ckpXdVRpYWdJNW9NckwtY08zQmI0bEJFME0tWVlyUVF1VE00eUpIUHRIbkxtWXdjdkhEZG9wNU9Oa0dzRGRsUXM4MnBBUlVFZGJuR044Z0djMS1mZlVHSG1Vdm0tSF9KZW4xV0FxN2RkQ3dwNU5HS0gyRE13WEZIYjlSdklDcFVabTljSW9MWjF0cGprallKbG1raU1JY3A5S3k3bVQzekhSNTR0cDdl?oc=5 · headline: A cancer blood test identified every local growth or recurrence in one rectal cancer study · publication: Stock Titangoogle_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMiqgFBVV95cUxNU3BHRG9jSlBJWS00VzU2c0ZJX3ZsQWVuRm5RT0JWZmNlLUhIUkY2cmdkRXJfeVdqMFJZeHpuaktmbi1iMXpycjVPbzNablpXVlktSmFyZTdMdXRhdkJ4ei1jYlI5UXBPTGl4UjRnYkFvcVdJNHhEdTdUaXJ3N1lRZ1l1V1ZnZGxDcG9mdlNGc0hTTktpQ2J4X19YekxxSTlYWEJIbHhOMWFHQQ?oc=5 · headline: Natera Reports Fourth Quarter and Full Year 2024 Financial Results · publication: BioSpacegoogle_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMilAFBVV95cUxPTi1uNzdNVFBObVo3bUVaNzZ6YXRKODdTYXVtU2ZFWEd3eV9aNlIyWTh6OHVnR1h2NGJHeUNOOXQxZmJkenY3clhhYzBIcC1Obng3VWVtZ3hORVAxcV81d0EtU0dyR3g2R1VVVEpKNEtPcmhMeUJZQWI4QWtfUGFDd0ZVb0xjU0s3QUwtcWZ4eVZ2bWhL?oc=5 · headline: Biggest life sciences companies in Austin area · publication: The Business Journalsgoogle_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMitwFBVV95cUxOSks5LTZERVlncmFNZ2dFRjYtZzZpRHIydkNWT0g2S2pES181aGdib3RuSzZob2h6b2FxTkx3R0d4QzN1dWFNQ3Fxa21ZRVlQRC1fdklwdWRoZzRpZGswVTRpbG8tM2RrdVlnQS1tS3MxblJSS1BkU1U0YkxWdWdKdW14WjJnRnBkSGV3RTJPcEtmRFN4cjFaalRQWHNBckJMTXpVeFZoRHp1d1hhSzFlOGhpYlYwZFE?oc=5 · headline: Natera Announces Publication of over 100 Peer-Reviewed Papers on SignateraTM · publication: BioSpacegoogle_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMi1AFBVV95cUxQS01IMGtLYWl2SVEybnp3RWlLWWFMRThFWkxnVHB4TzEwTG9tQTVwaGx4X2RTXzZ4YUxxRDRlUUkzZUt0OXllT0lKVWpDSEVjV0FzbWNuVnA0SWhGUjZXWDdKekM1aF9fRHdod1lHelBpdDhTX0RHX1N0QmdlVHM3ZjJLeTYxOUhKQjhDcnAyQ3NiakNfbktUNS1oVEg1SEw2OWJNV3JJbXRlWFBtUWN5YjZuaDVJbENOeUN6dG9HNS0zSkpYOU4tdkNmcHlEQTc3WVNHRw?oc=5 · headline: Signatera™ CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC) · publication: BioSpacegoogle_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMipgFBVV95cUxObDBuZUhQWllBeGJNM1pGcGExT2ZnTEYwOFRBU2t3ZUFHYmZhQjdrbmhKZ2d2RWx4UHo4bjZ5Ti1td0o2Z0YyT2tBbHNyM0M3Z1ZhYjdlalFpVWlfdEMtN1ZpbEhuWEpxZERxQ1VJdTF6cXFxQlNhQTh5MzJkYUxKMXNwckl3a3VwUzZ4LUlla3NhNkk1al9NdG41QlRva0pmMDJmX1dn?oc=5 · headline: Alliance Foundation Trials and Natera Announce AFT-70 NAVIGATE: a Global, Randomized, Phase III Trial Evaluating Genentech’s Oral Selective Estrogen Receptor Degrader (SERD) with Signatera™ MRD-Guided CDK4/6 Inhibitor Therapy in Breast Cancer · publication: Yahoo Financegoogle_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMiugFBVV95cUxPREFGdHkzSS03MU1ZeUhUVnM3eHNWNGUtZklmWjR1Z1dwWGlzMWNwb3M3cHV1UTdVcUNtd3hpSWgybUZ3dVZzaXVuR3BfN25nempVTlF2RmRLUkFtUzQtaHdCVFZJX3dZNmlxUUhzY3pfQUNwTU1NLWh1X292aWhSSFFTaVlJb3BIeWk1N0ZGOUM2RF90bmg4STU5WlJrdnREbnJUem8zUnhWaHZ6N2ZHbmxHajV3eUNLakE?oc=5 · headline: FDA Grants Breakthrough Device Designation to Natera’s Multi-Cancer Early Detection Assay · publication: OncLivegoogle_news · 10/15/2026